ES2085832B1 - Profarmacos de la 5,5-difenilhidantoina. - Google Patents

Profarmacos de la 5,5-difenilhidantoina.

Info

Publication number
ES2085832B1
ES2085832B1 ES09401625A ES9401625A ES2085832B1 ES 2085832 B1 ES2085832 B1 ES 2085832B1 ES 09401625 A ES09401625 A ES 09401625A ES 9401625 A ES9401625 A ES 9401625A ES 2085832 B1 ES2085832 B1 ES 2085832B1
Authority
ES
Spain
Prior art keywords
propharmacs
hydantoine
diphenyl
product
propharmaces
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES09401625A
Other languages
English (en)
Other versions
ES2085832A1 (es
Inventor
Estrem Tomas Roca
Cartes Joan Bosch
Berrozpe Josep Domenech
Vidal Rossend Obach
Zurita Pelayo Rubio
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratorios Rubio SA
Original Assignee
Laboratorios Rubio SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios Rubio SA filed Critical Laboratorios Rubio SA
Priority to ES09401625A priority Critical patent/ES2085832B1/es
Priority to EP95500085A priority patent/EP0693481A1/en
Priority to IL114236A priority patent/IL114236A/en
Priority to JP7185350A priority patent/JPH08183777A/ja
Publication of ES2085832A1 publication Critical patent/ES2085832A1/es
Application granted granted Critical
Publication of ES2085832B1 publication Critical patent/ES2085832B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

PROFARMACOS DE LA 5,5-DIFENILHIDANTOINA. LA PRESENTE INVENCION TRATA DE UN PRODUCTO DE FORMULA (I), QUE ES UN NUEVO PROFARMACO DE LA FENITOINA, ASI COMO DE SUS SOLVATOS Y DE SUS SALES DE ADICION TERAPEUTICAMENTE ACEPTABLES. ESTE PRODUCTO PRESENTA UNA SOLUBILIDAD SIGNIFICATIVAMENTE MAYOR QUE LA PROPIA FENITOINA. ADEMAS, SORPRENDENTEMENTE, SU VELOCIDAD DE HIDROLISIS ES MUCHO MAYOR QUE LA DE OTROS PROFARMACOS CONOCIDOS DE LA FENITOINA, LO QUE LO CONVIERTE EN POTENCIALMENTE UTIL COMO AGENTE ANTIEPILEPTICO Y ANTIARRITMICO.
ES09401625A 1994-07-22 1994-07-22 Profarmacos de la 5,5-difenilhidantoina. Expired - Fee Related ES2085832B1 (es)

Priority Applications (4)

Application Number Priority Date Filing Date Title
ES09401625A ES2085832B1 (es) 1994-07-22 1994-07-22 Profarmacos de la 5,5-difenilhidantoina.
EP95500085A EP0693481A1 (en) 1994-07-22 1995-06-14 Prodrugs of 5,5-diphenylhydantoin as antiepileptic and antiarrhythmic agents
IL114236A IL114236A (en) 1994-07-22 1995-06-20 5, 5-diphenylhydantoin derivatives, pharmaceutical compositions containing the same and a process for the preparation thereof
JP7185350A JPH08183777A (ja) 1994-07-22 1995-07-21 ５、５−ジフェニルヒダントインのプロドラッグ

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES09401625A ES2085832B1 (es) 1994-07-22 1994-07-22 Profarmacos de la 5,5-difenilhidantoina.

Publications (2)

Publication Number Publication Date
ES2085832A1 ES2085832A1 (es) 1996-06-01
ES2085832B1 true ES2085832B1 (es) 1997-01-16

Family

ID=8287022

Family Applications (1)

Application Number Title Priority Date Filing Date
ES09401625A Expired - Fee Related ES2085832B1 (es) 1994-07-22 1994-07-22 Profarmacos de la 5,5-difenilhidantoina.

Country Status (4)

Country Link
EP (1) EP0693481A1 (es)
JP (1) JPH08183777A (es)
ES (1) ES2085832B1 (es)
IL (1) IL114236A (es)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4163058A (en) * 1977-04-22 1979-07-31 Interx Research Corporation Derivatives of 5,5-diphenylhydantoin exhibiting enhanced solubility and the therapeutic use thereof
US4260769A (en) 1977-04-22 1981-04-07 Interx Research Corporation 5,5-Diphenylhydantoins
US5002935A (en) * 1987-12-30 1991-03-26 University Of Florida Improvements in redox systems for brain-targeted drug delivery
DK24089D0 (da) 1989-01-20 1989-01-20 Hans Bundgaard Novel prodrug derivatives of biologically active agents containing hydroxyl groups or nh-acidic groups

Also Published As

Publication number Publication date
IL114236A (en) 1998-06-15
ES2085832A1 (es) 1996-06-01
JPH08183777A (ja) 1996-07-16
IL114236A0 (en) 1995-10-31
EP0693481A1 (en) 1996-01-24

Similar Documents

Publication Publication Date Title
DE59914996D1 (en) Heterocyclisch substituierte amide als calpainhemmer
MX9805306A (es) Composiciones decoloradoras del cabello.
MX9710373A (es) Fenilcetoenoles 2,4,5-trisubstituidos para el empleo como pesticidas y herbicidas.
GB2381470A (en) A system and method of displaying a reward selection and win-or-lose result on a terminal
ES2188228T3 (es) Dispositivo de observacion del interior de un cuerpo que produce una calidad de observacion perfeccionada.
ES2161886T3 (es) Composiciones en barra de gel que comprenden gelificantes opticamente enriquecidos.
GR960100438A (el) Νεα παρασιτοκτονα.
EP1010749A3 (en) Activated liquid bleaching compositions
AU5763598A (en) Injection device
MX9601994A (es) Profarmacos de derivados de paclitaxel.
FR2848824B1 (fr) Composition de revetement des fibres keratiniques presentant un caractere filant
FR2728212B1 (es)
FI954836A0 (fi) Muovimateriaalien tuottaminen mikro-organismeista
ES2085832B1 (es) Profarmacos de la 5,5-difenilhidantoina.
YU22694A (sh) Kristalni monohidrat spirostanil glikozida
BG102838A (en) Compositions containing hiv protease inhibitor such as vx 478, and water soluble vitamin b as vitamin e-trgs
ES2065307T3 (es) Producto y procedimiento para el moldeado permanente del cabello.
EP1073447A4 (en) N1-MODIFIED GLYCOPEPTIDES
AU5164698A (en) Sprayable disinfecting compositions and processes for disinfecting surfaces therewith
ES2140897T3 (es) Mezclas fungicidas.
DE69831737D1 (de) Neurotrypsin
BRPI0411082A (pt) composição alvejante, e, método para alvejar uma mancha têxtil
WO2002000177A3 (de) Mittel zur oxidativen farbveränderung keratinischer fasern die ein verdickungssystem enthält
IT1272274B (it) Composizioni erbicide.
MX9602804A (es) Derivados del 3-aril-alquenil-1,2,4-oxadiazol y su uso como parasiticidas para animales.

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 19940722

Kind code of ref document: B1

Effective date: 19940722

FD2A Announcement of lapse in spain

Effective date: 20180806